(NaturalNews) Hypocrisy on the part of the FDA regarding the effectiveness of marijuana as medicine has once again been clearly documented as the agency – after insisting publicly for years that ‘cannabis has no medicinal value’ – is now ready to grant a license to GW Pharmaceuticals to begin marketing a cannabinoid-based drug which will be used to treat multiple sclerosis.
The truth is that the government has known for decades that marijuana does indeed have medicinal value. In fact, it has issued many patents for cannabinoid-based drugs.
Similar cannabis-based formulations created by GW Pharmaceuticals and other drug companies are expected to treat autism, muscular dystrophy, glioma, ovarian and pancreatic cancer and schizophrenia, as well as epileptics. Orders for this product are expected to grow 40 times over in the coming years.
For well over half a century, the medicinal and recreational use of marijuana has…
View original post 508 more words